We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+4.83%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$498M
AUM Growth
+$202M
Cap. Flow
+$192M
Cap. Flow %
38.62%
Top 10 Hldgs %
7.15%
Holding
856
New
312
Increased
243
Reduced
122
Closed
179

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$5.17M
2
BIDU icon
Baidu
BIDU
+$4.36M
3
BIIB icon
Biogen
BIIB
+$4.02M
4
BHC icon
Bausch Health
BHC
+$3.69M
5
BABA icon
Alibaba
BABA
+$2.95M

Sector Composition

Rank Sector Weight
1 Technology 14.35%
2 Healthcare 14.26%
3 Industrials 12.91%
4 Financials 11.07%
5 Consumer Discretionary 10.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KLIC icon
351
Kulicke & Soffa
KLIC
$4.78B
$547K 0.11%
34,972
+8,027
+30% +$125K
NEWP
352
DELISTED
NEWPORT CORP
NEWP
$547K 0.11%
28,674
+10,549
+58% +$204K
OMCL icon
353
Omnicell
OMCL
$1.68B
$546K 0.11%
15,555
-414
-3% -$13.6K
WRB icon
354
W.R. Berkley
WRB
$26.6B
$546K 0.11%
36,504
-5,700
-14% -$84.7K
CNMD icon
355
CONMED
CNMD
$1.47B
$545K 0.11%
10,802
+1,479
+16% +$72.5K
KAMN
356
DELISTED
Kaman Corp
KAMN
$545K 0.11%
12,845
+3,407
+36% +$137K
PBCT
357
DELISTED
People's United Financial Inc
PBCT
$544K 0.11%
35,801
-487
-1% -$7.22K
DNY
358
DELISTED
DONNELLEY R R & SONS CO
DNY
$544K 0.11%
+28,359
New +$544K
NXGN
359
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$543K 0.11%
33,994
+5,452
+19% +$90.2K
NOC icon
360
Northrop Grumman
NOC
$81.2B
$542K 0.11%
3,368
-616
-15% -$98.5K
PCG icon
361
PG&E
PCG
$38.5B
$542K 0.11%
+10,216
New +$564K
BRKL
362
DELISTED
Brookline Bancorp
BRKL
$540K 0.11%
+53,712
New +$523K
OVTI
363
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
$538K 0.11%
20,412
+3,512
+21% +$94.1K
LMNX
364
DELISTED
Luminex Corp
LMNX
$537K 0.11%
+33,590
New +$564K
PDLI
365
DELISTED
PDL BioPharma, Inc.
PDLI
$537K 0.11%
76,278
+13,586
+22% +$98.4K
SYK icon
366
Stryker
SYK
$130B
$536K 0.11%
5,814
+237
+4% +$22.1K
NTUS
367
DELISTED
Natus Medical Inc
NTUS
$536K 0.11%
+13,572
New +$500K
BRCD
368
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
$536K 0.11%
45,204
-16,648
-27% -$199K
MD icon
369
Pediatrix Medical
MD
$2.2B
$535K 0.11%
+7,373
New +$513K
PMT
370
PennyMac Mortgage Investment
PMT
$842M
$535K 0.11%
25,150
-4,514
-15% -$97.5K
AEIS icon
371
Advanced Energy
AEIS
$13B
$532K 0.11%
20,716
-4,485
-18% -$114K
UFCS icon
372
United Fire Group
UFCS
$1.4B
$532K 0.11%
16,730
+3,192
+24% +$93.7K
GTS
373
DELISTED
Triple-S Management Corporation
GTS
$531K 0.11%
+28,065
New +$585K
MCY icon
374
Mercury Insurance
MCY
$6.07B
$530K 0.11%
9,186
-3,671
-29% -$206K
IVR icon
375
Invesco Mortgage Capital
IVR
$805M
$529K 0.11%
3,408
+259
+8% +$40.4K

Similar funds

Vident Investment Advisory's Q1 2015 Portfolio in Review

As of Q1 2015, Vident Investment Advisory held 856 positions worth $498M, up 68% from $297M the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.

Vident Investment Advisory deployed $192M of net new capital in Q1 2015, opening 312 new positions and adding to 243 existing holdings. Its largest new stake was Apple: 171,220 shares worth $5.33M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Chevron, an estimated $1.05M trimmed.

  • Vident Investment Advisory's largest Q1 2015 buy was Apple: 171,220 shares worth $5.33M.
  • Vident Investment Advisory added most to Spirit AeroSystems in Q1 2015, an estimated $2.61M increase.
  • Vident Investment Advisory's biggest Q1 2015 reduction was Chevron, cutting an estimated $1.05M.
  • Vident Investment Advisory fully exited Coca-Cola Consolidated in Q1 2015, selling an estimated $1.81M.
  • Vident Investment Advisory's ten largest holdings make up 7.2% of its $498M portfolio in Q1 2015.
  • Vident Investment Advisory opened 312 new positions and closed 179 in Q1 2015.
  • Vident Investment Advisory's portfolio value rose 68% quarter-over-quarter to $498M.

Based on Vident Investment Advisory's 13F filing for Q1 2015, filed 13 May 2015.